A. Total (left) and relative (right) power 15 min after
i.p. injection of the neurosteroid. Analysis of total power revealed an increase
in the δ, θ and α frequency ranges in WT animals in
comparison to mutant mice (two way RM ANOVA, Interaction F(4,64) =
6.78, p < 0.001; Frequency F(4,64) = 19.09, p < 0.001,
Genotype F(1,16) = 11.96, p = 0.003; post-hoc presented on Figure).
Analysis of difference from baseline (relative power) revealed δ rise in
WT and β rise in mutant animals (two way RM ANOVA, Interaction
F(4,64) = 4.652, p = 0.002; Frequency F(4,64) = 4.976,
p = 0.001, Genotype F(1,16) = 1.025, p = 0.326; post-hoc presented on
Figure). B. Total (left) and relative (right) power 30 min after
i.p. injection of the neurosteroid. Analysis of total power revealed an increase
in the θ and α frequency ranges (two way RM ANOVA, Interaction
F(4,64) = 6.86, p < 0.001; Frequency F(4,64) =
24.76, p < 0.001, Genotype F(1,16) = 6.807, p = 0.019;
post-hoc presented on Figure). Analysis of differences from baseline (relative
power) revealed no change between baseline and EpiP. C. Total
(left) and relative (right) power 60 min after i.p. injection of the
neurosteroid. Analysis of total power revealed an increase in the δ,
θ and α frequency ranges in WT animals (two way RM ANOVA,
Interaction F(4,64) = 7.781, p < 0.001; Frequency
F(4,64) = 22.04, p < 0.001, Genotype F(1,16) =
9.197, p = 0.008; post-hoc presented on Figure). Analysis of difference from
baseline (relative power) revealed rise in δ on WT animals (two way RM
ANOVA, Interaction F(4,64) = 3.30, p = 0.016; Frequency
F(4,64) = 5.020, p = 0.001, Genotype F(1,16) = 0.108,
p = 0.747; post-hoc presented on Figure). Analysis of recordings was averaged
from 11 (WT) and 7 (CaV3.1 KO) animals. *p < 0.05, **p
< 0.01, ***p < 0.001